Avodart Cost in Iowa 2026: Dutasteride Pricing, Insurance, and Savings

Current Dutasteride Prices in Iowa

The most accurate answer is a same-day quote for the exact prescription at the exact pharmacy. Prices can differ between two pharmacies in the same city and can change with quantity, manufacturer, network status, deductible, and coupon terms.

A national price guide, accessed July 31, 2026, displayed a discounted cash range of approximately $8.12 to $16.92 for 30 generic 0.5 mg capsules and approximately $14.78 to $35.16 for 90 capsules 7. Those are national guide prices, not guaranteed Iowa quotes and not insurance copays.

The previous version of this page claimed a fixed $25 Iowa average, a $290 brand list price, specific Walgreens, Hy-Vee, CVS, and Walmart prices, and a $40 compounded price without a reproducible Iowa survey. Those figures have been removed. A useful price comparison should record:

• drug name, strength, and quantity;
• brand required or generic permitted;
• pharmacy location;
• insurance price versus cash price;
• discount-card price and terms;
• mail-order eligibility; and
• the date and time of the quote.

What Dutasteride Is Approved to Treat

The current DailyMed label says Avodart is indicated for symptomatic benign prostatic hyperplasia in men with an enlarged prostate. It can improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of BPH-related surgery. It can also be used with the alpha blocker tamsulosin for symptomatic BPH in men with an enlarged prostate 1.

The labeled dose is one 0.5 mg capsule once daily, and the capsule should be swallowed whole 1. Dutasteride inhibits both type 1 and type 2 5-alpha-reductase, lowering conversion of testosterone to dihydrotestosterone. The label reports that one and two weeks of daily dosing reduced median serum DHT concentrations by 85% and 90%, respectively 1.

Dutasteride is also discussed online for androgenetic alopecia, but hair loss is not an FDA-approved Avodart indication 1. A prescription written for hair loss therefore has a different clinical and coverage context from a BPH prescription.

What the BPH Trial Evidence Shows

The four-year CombAT randomized trial enrolled 4,844 men age 50 or older with moderate-to-severe lower urinary tract symptoms, prostate volume at least 30 mL, and other risk features. Participants received dutasteride, tamsulosin, or the combination. Combination therapy was superior to tamsulosin but not dutasteride for reducing the risk of acute urinary retention or BPH-related surgery; it was superior to both monotherapies for reducing overall BPH clinical progression 2.

That evidence supports treatment decisions in men matching the trial’s BPH population. It does not prove that every person needs combination therapy, and it does not establish insurance coverage or a retail price. The earlier page linked the CombAT claim to a malformed PubMed address; the verified record is PMID 19825505.

Iowa Medicaid Coverage in July 2026

The Iowa Medicaid preferred drug list effective July 1, 2026 places these products in the benign prostatic hypertrophy class 3:

The PDL’s comment 39 says the brand is grandfathered for members already established on it 3. This table replaces the prior blanket exclusion claim with the current, product-specific formulary status. A non-preferred listing can involve prior authorization or use of a preferred alternative, and member-specific coverage still depends on the current program and claim details.

Iowa Medicaid publishes current PDL documents and prior-authorization resources on its official formulary hub 4. The member or prescriber should use the effective document for the fill date rather than relying on a cached article or an earlier year’s list.

A Reproducible Way to Check the Lowest Price

1. Confirm the indication and prescription. The prescriber determines whether dutasteride is appropriate and whether generic substitution is acceptable.
2. Check the exact formulary. Search both “dutasteride” and “Avodart,” and record the tier or preferred status, prior authorization, quantity limit, and preferred pharmacy.
3. Ask for the insurance claim price. A formulary listing does not reveal the member’s deductible or copay.
4. Request a cash quote. Ask the pharmacy for the price without submitting insurance.
5. Compare a reputable discount quote. Match strength, quantity, pharmacy, and date. A coupon is not insurance and generally does not count toward an insurance deductible.
6. Compare 30 and 90 capsules. A larger fill can have a lower per-capsule price, but only when the prescription and plan permit it.
7. Recheck before pickup. Online estimates can change and do not bind the pharmacy.

This process is stronger than a statewide “average” because every input can be verified.

Commercial Insurance and Medicare

Commercial plans and Medicare Part D plans set their own formularies and cost sharing. Generic dutasteride and brand Avodart may occupy different tiers or have different restrictions. Even when a drug is listed, the member’s price may change before and after the deductible 6.

For Medicare, use the official Plan Compare tool and enter the exact medication, dosage, quantity, and pharmacy 6. For employer or individual coverage, use the insurer’s current member portal or call the number on the insurance card. Ask four separate questions:

• Is generic dutasteride covered for this indication?
• Is prior authorization or step therapy required?
• Which pharmacies and quantities receive the lowest plan price?
• Is brand Avodart covered differently from the generic?

The previous page named specific Iowa insurers and asserted universal tiers and copays without plan documents. Those statements have been removed because a carrier name alone cannot predict one member’s benefit.

Prior Authorization: What Evidence Helps

If the product is non-preferred, the plan’s current criteria control. A useful request commonly identifies the diagnosis, prostate size or other relevant BPH findings, symptom severity, prior therapies, adverse effects or contraindications, and why the preferred option does not meet the patient’s need. The prescriber should answer the actual form rather than copy a generic appeal script.

There is no published Iowa figure supporting the prior page’s claim that neighboring-state approvals run 30% to 50%, and there is no universal six-month finasteride-failure rule in the state PDL itself 3. Both claims have been removed.

Telehealth Access in Iowa

An Iowa-authorized clinician may use telehealth when the professional rules and standard of care are met. Iowa’s current advanced-practice nursing rule, for example, says telehealth is permitted, requires Iowa licensure for a patient located in Iowa, applies the same standard of care as in-person practice, and permits prescribing when consistent with that standard 5. It does not guarantee that dutasteride will be prescribed.

A clinician may need symptom history, medication and allergy lists, prostate evaluation records, PSA history, urinary findings, and other information before making a decision. Whether an in-person exam or further testing is necessary depends on the presentation.

Safety Details That Affect the Decision

The label contains several clinically important points 1:

• dutasteride lowers serum PSA by about 50% within three to six months, so clinicians establish a new baseline and interpret later PSA values in that context;
• sexual adverse reactions and breast disorders were reported in trials;
• the capsule should not be handled by someone who is pregnant or could become pregnant if it is leaking, because dutasteride can be absorbed through skin;
• blood donation is deferred until at least six months after the last dose; and
• dutasteride is contraindicated in pregnancy and in patients with hypersensitivity to dutasteride, other 5-alpha-reductase inhibitors, or product components.

Price should be compared only after the medication and indication make clinical sense. The current label is the source of truth for product-specific warnings, not an old 2008 label or a coupon page 1.